Market Research Logo

ProAxsis Ltd - Product Pipeline Analysis, 2018 Update

Summary

ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases in complex biological samples with a high level of specificity and selectivity. Its active neutrophil elastase immunoassay is also used to predict future risk of aggravation in bronchiectasis. ProAxsis also provide biomarker services, clinical trial and pharma services, and academic support services. The company provides peptide-based inhibitor design and synthesis, activity-based steady state assays, ELISAs and enzyme kinetics and compound characterization, among others. Its products is used for detection and measurement of active protease biomarkers of disease. ProAxsis is headquartered in Belfast, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company ProAxsis Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


  • ProAxsis Ltd Company Overview
    • ProAxsis Ltd Company Snapshot
    • ProAxsis Ltd Pipeline Products and Ongoing Clinical Trials Overview
      • Table ProAxsis Ltd Pipeline Products and Ongoing Clinical Trials Overview
      • Table ProAxsis Ltd Pipeline Products by Equipment Type
      • Table Figure 1: ProAxsis Ltd Pipeline Products by Equipment Type
      • Table ProAxsis Ltd Pipeline Products by Indication
  • ProAxsis Ltd – Pipeline Analysis Overview
    • ProAxsis Ltd - Key Facts
      • Table ProAxsis Ltd, Key Facts
    • ProAxsis Ltd - Major Products and Services
      • Table ProAxsis Ltd, Major Products and Services
    • ProAxsis Ltd Pipeline Products by Development Stage
      • Table Figure 2: ProAxsis Ltd Pipeline Products by Development Stage
      • Table ProAxsis Ltd Number of Pipeline Products by Development Stage
      • Table ProAxsis Ltd Pipeline Products Summary by Development Stage
  • ProAxsis Ltd Pipeline Products Overview
    • ProteaseTag - COPD
      • ProteaseTag - COPD Product Overview
        • Table ProteaseTag - COPD - Product Status
        • Table ProteaseTag - COPD - Product Description
    • ProteaseTag - Cystic Fibrosis
      • ProteaseTag - Cystic Fibrosis Product Overview
        • Table ProteaseTag - Cystic Fibrosis - Product Status
        • Table ProteaseTag - Cystic Fibrosis - Product Description
    • ProteaseTag Active Immuno Assay - Pancreatic Elastase
      • ProteaseTag Active Immuno Assay - Pancreatic Elastase Product Overview
        • Table ProteaseTag Active Immuno Assay - Pancreatic Elastase - Product Status
        • Table ProteaseTag Active Immuno Assay - Pancreatic Elastase - Product Description
    • ProteaseTag Active Immunoassay - Tryptase
      • ProteaseTag Active Immunoassay - Tryptase Product Overview
        • Table ProteaseTag Active Immunoassay - Tryptase - Product Status
        • Table ProteaseTag Active Immunoassay - Tryptase - Product Description
  • ProAxsis Ltd - Key Competitors
  • ProAxsis Ltd - Key Employees
    • Table ProAxsis Ltd, Key Employees
  • ProAxsis Ltd - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
      • Table ProAxsis Ltd, Subsidiaries
  • Recent Developments
    • ProAxsis Ltd, Recent Developments
      • Jun 18, 2018: ProAxsis presenting further data at COPD 11 Conference
      • Jun 01, 2018: ProAxsis Awarded Invest NI Grant for Development of New ProteaseTag Products
      • Jun 01, 2018: ProAxsis Receives Further Backing from Invest Northern Ireland Under EU investment
      • May 02, 2018: ProAxsis to Present New Data Underscoring the Importance of Neutrophil Elastase in COPD at ATS 2018
      • Feb 15, 2018: ProAxsis reports first NEATstik sale
      • Feb 15, 2018: ProAxsis reaches the commercialisation stage of its technology by reporting its first NEATstik sale
      • Jan 16, 2018: NetScientific Portfolio Update
      • Jan 08, 2018: ProAxsis Achieves CE Mark and Launches its ProteaseTag Active Plasmin Immunoassay
      • Dec 05, 2017: ProAxsis abstracts at 2017 British Thoracic Society Winter Meeting
      • Nov 21, 2017: ProAxsis provides update on commercialisation progress
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report